The business and patient case for drug delivery device innovation in biosimilar products
Manufacturing Chemist covers up-to-the-minute developments across all the areas of the pharma supply chain as well as comprehensive technical articles, market analysis and insights of those who are shaping the industry on a daily basis. Its international coverage and in-depth articles on key topics make it an indispensable read for those working in or around the global pharmaceutical market place. Its readers includes individuals with an interest in processing and packaging for the pharmaceutical and cosmetics industries, the pharmaceutical raw materials industry and the general chemical industries.
In their April issue our Regulatory Affairs Manager, Darren Mansell explores the business and patient case for drug delivery innovation in biosimilar products. With the growing trend for patient self-administration, the drug delivery device may play a critical role in retaining patients in the long term. Find out more on pages 18-19 in the link below.